Olson Center
Dr. Leland Olson and Dorothy Olson
Founded in 1993 through the generosity of the late Dr. Leland J. Olson and his wife, Dorothy, the Olson Center provides ongoing funding for community education, research, and novel clinical programs.
A long-standing goal of the donors was reached in 2007 with the opening of the Olson Center for Women's Health outpatient facility located in the Durham Outpatient Center on the UNMC campus. There is also a branch location on the Village Pointe campus. This center is nationally unique, combining specialty and general OB-GYN, prenatal diagnosis, endocrinology, physical therapy, and mammography/women’s imaging. The Olson Center is one of the largest ambulatory clinic operations at Nebraska Medicine.
Located within the clinic at the Durham Outpatient Center, the Olson Women’s Health Resource Center provides women's health education to the community, patients, health care providers, and students in the Omaha area and nationwide with conferences, virtual webinars, and educational publications.
Governance and Funded Projects
Advisory Committee President
Members
- Karen Olson, MD (retired)
- Nancy Olson
- David Olson, MD (retired)
- Kendra Swanson, MD
- Gail Walling‑Yanney, MD (retired)
- Kenneth W. Bayles, PhD (UNMC Vice Chancellor for Research)
- Donald Gibbens, MD
- Director’s Office support, Dr. John Davis
- Women’s Health Resource Center, Lana Molczyk
- Resident CME/Travel and Research Fund, Dr. Laura Cudzilo
- The Olson Postdoctoral Research Fellowship, Dr. John Davis
- Fetal and Neonatal Loss Bereavement Program, Dr. Teresa Berg
- Seminar Series – Nebraska Center for Women’s Health Research, Dr. John Davis
- Clinical Research Coordinator, Gyn Oncology, Dr. Lindsey McAlarnen
- Clinical Research Coordinator, Dr. Sarosh Rana
- Research Equipment, Dr. Kendra Clark
- Genetics Project - Gyn and Breast Disease, Dr. Jennifer Griffin
In total, the approved budget for FY25-26 is $924,200, with 29% allocated to research, 49% allocated to education, 8% allocated to administrative support, 10% allocated to patient experience, and 4% going towards novel clinical activity.